Angelina Tadros
November 23, 2025
Genetics
Dr. Barbato
New Gene Therapy Brings Hope For Timothy Syndrome
Timothy syndrome is an extremely rare and severe genetic disorder caused by mutations in the CACNA1C gene, which encodes for a calcium channel that is crucial for normal cellular communication functioning. Calcium channels are active in many tissues, therefore the syndrome unfortunately affects multiple organ systems. Children with Timothy syndrome commonly present with dangerous cardiac arrhythmias (which is an abnormal heartbeat caused by malfunctioning electrical impulses, this could result in a heartbeat too fast, too slow, or irregular) neurodevelopmental delays, autism related behaviors, seizures, immune dysfunction, and physical abnormalities like syndactyly (webbed fingers or toes). This condition is usually life threatening in early childhood, and until now there hasn't been any treatments, or talk of treatments, to address the underlying cellular pathology.
A new NIH backed study published in Nature shows a new gene based treatment approach for Timothy syndrome that may be promising. Researchers at Stanford University used cells from patients to create brain organoids and assembloids, which are 3D tissue models that mimic human neural development. They then tested antisense oligonucleotides (ASOs), short strands of genetic material made to change gene expression, these specifically targeted the mutated exon 8a of CACNA1C that causes the disorder. By guiding cells to use the healthy version of the gene (exon 8), the ASO treatment successfully restored normal calcium channel functionality The improvements lasted for at least 90 days in human derived tissue, from the lab grown organoids and in organoids transplanted into rat brains.
This study is huge and represents a major step forward in this area of study, it uncovers something brand new that no one has been able to come close to as of now. This is major for Timothy disease and for gene based therapies targeting neurodevelopmental disorders in general. Restoring normal function in the calcium channel in the patient derived organoids shows that this mutation is reversible and provides a pathway to fully correct this rare disorder. This is important because this disorder was previously thought to be untreatable. While more work will obviously be needed in order to ensure safety and figure out how to successfully deliver this therapy to patients, these results provide hope and point to a possible first treatment that could change the course of the disease entirely and save many lives.
Figure 1
This image from the study published in Nature, shows transplanted human cortical organoids from people with Timothy Syndrome.
Sources
